Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N6HF | ISIN: DK0061078425 | Ticker-Symbol: S7C
Frankfurt
24.01.25
15:29 Uhr
0,103 Euro
-0,008
-7,24 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
STENOCARE A/S Chart 1 Jahr
5-Tage-Chart
STENOCARE A/S 5-Tage-Chart

Aktuelle News zur STENOCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSTENOCARE A/S: Conditional Rights Issue subscribed to 45.0 percent1
MoSTENOCARE - Final deadline for Subscription to New Shares at DKK 0.50 Each1
17.01.STENOCARE - Final deadline Soon for Subscription to New Shares at DKK 0.50 Each1
15.01.STENOCARE - The new innovative ASTRUM 10-10 product is now available for German patients1
10.01.STENOCARE A/S announces guarantee commitments in ongoing rights issue2
STENOCARE Aktie jetzt für 0€ handeln
09.01.STENOCARE - Deadline soon to subscribe for new shares at DKK 0.50 each1
07.01.STENOCARE A/S: The subscription period in Stenocare's conditional rights issue begins today for the time limited offer of DKK 0,50 per new share1
03.01.STENOCARE's Innovative ASTRUM 10-10 Product Now Available for Norwegian Patients2
02.01.XFRA CAPITAL ADJUSTMENT INFORMATION - 02.01.2025216Das Instrument S7C DK0061078425 STENOCARE DK-,08 EQUITY wird cum Kapitalmassnahme gehandelt am 02.01.2025 und ex Kapitalmassnahme am 03.01.2025 The instrument S7C DK0061078425 STENOCARE DK-,08 EQUITY...
► Artikel lesen
18.12.24STENOCARE A/S: Conditional Rights Issue of up to 20.2 mDKK1
18.12.24Communiqué from extraordinary general meeting in STENOCARE2
17.12.24Stenocare A/S: STENOCARE Gains Danish Approval for New Medical Cannabis CBD100 oil73STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO Stenocare has received approval from the Danish Medicines Agency to start selling a new medical cannabis oil product to Danish...
► Artikel lesen
10.12.24STENOCARE 3.0 Strategy: Management Shares Insights in Exclusive Interview with Proinvestor.com2
03.12.24Danish Medical Marijuana Producer Stenocare To Launch Patented 10mg THC And 10mg CBD Oil In Norway1
02.12.24STENOCARE - Innovative New ASTRUM Product Officially Approved for Sale in Norway2
28.11.24STENOCARE Celebrates Denmark's Permanent Legalisation of Medical Cannabis1
26.11.24STENOCARE 3.0: Shifting Strategy to Focus on Trading and exit from Production1
26.11.24Notice to Extraordinary General Meeting in STENOCARE A/S2
19.11.24STENOCARE Welcomes Danish Health Minister's Decision to Permanently Legalise Medical Cannabis for Patients1
05.11.24Stenocare A/S: Interim Report Third Quarter 2024137STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2024 - 30.09.2024. The report, which has not been reviewed...
► Artikel lesen
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1